Joanna Sikora

732 total citations
39 papers, 500 citations indexed

About

Joanna Sikora is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Joanna Sikora has authored 39 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 13 papers in Internal Medicine and 11 papers in Surgery. Recurrent topics in Joanna Sikora's work include Antiplatelet Therapy and Cardiovascular Diseases (26 papers), Venous Thromboembolism Diagnosis and Management (13 papers) and Acute Myocardial Infarction Research (10 papers). Joanna Sikora is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (26 papers), Venous Thromboembolism Diagnosis and Management (13 papers) and Acute Myocardial Infarction Research (10 papers). Joanna Sikora collaborates with scholars based in Poland, Austria and Canada. Joanna Sikora's co-authors include Jacek Kubica, Katarzyna Buszko, Michał Piotr Marszałł, Eliano Pio Navarese, Piotr Adamski, Małgorzata Ostrowska, Jolanta M. Siller‐Matula, Bernd Jilma, Marek Koziński and Wiktor Dariusz Sroka and has published in prestigious journals such as Circulation, PLoS ONE and Scientific Reports.

In The Last Decade

Joanna Sikora

39 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna Sikora Poland 11 380 141 122 55 32 39 500
Tonny Nielsen Denmark 9 965 2.5× 227 1.6× 133 1.1× 22 0.4× 25 0.8× 12 998
Siva Suryadevara United States 15 613 1.6× 301 2.1× 170 1.4× 12 0.2× 18 0.6× 34 685
Andrea Rivas United States 10 301 0.8× 152 1.1× 75 0.6× 13 0.2× 18 0.6× 20 375
Olivier Barthélemy France 10 348 0.9× 180 1.3× 62 0.5× 10 0.2× 12 0.4× 15 415
Udo Steigerwald Germany 8 176 0.5× 95 0.7× 75 0.6× 16 0.3× 33 1.0× 17 402
Nikolaus Sarafoff Germany 16 996 2.6× 301 2.1× 262 2.1× 32 0.6× 110 3.4× 26 1.2k
Jeremy S. Paikin Canada 13 342 0.9× 85 0.6× 173 1.4× 60 1.1× 30 0.9× 18 537
Julia Maria Kubica Poland 5 243 0.6× 352 2.5× 39 0.3× 16 0.3× 24 0.8× 9 542
Giovanni Maria Vescovo Italy 15 439 1.2× 158 1.1× 44 0.4× 20 0.4× 157 4.9× 50 610
Howard Rutman United States 13 500 1.3× 72 0.5× 98 0.8× 33 0.6× 53 1.7× 19 596

Countries citing papers authored by Joanna Sikora

Since Specialization
Citations

This map shows the geographic impact of Joanna Sikora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Sikora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Sikora more than expected).

Fields of papers citing papers by Joanna Sikora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Sikora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Sikora. The network helps show where Joanna Sikora may publish in the future.

Co-authorship network of co-authors of Joanna Sikora

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Sikora. A scholar is included among the top collaborators of Joanna Sikora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Sikora. Joanna Sikora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sikora, Joanna, et al.. (2024). Impact of Levosimendan and Its Metabolites on Platelet Activation Mechanisms in Patients during Antiplatelet Therapy—Pilot Study. International Journal of Molecular Sciences. 25(3). 1824–1824. 1 indexed citations
2.
Sikora, Joanna, et al.. (2024). Exploring the Interplay of Uric Acid and Advanced Oxidation Protein Products Following Myocardial Infarction. Applied Sciences. 14(5). 1983–1983. 1 indexed citations
3.
Stolarek, Wioleta, et al.. (2022). High on-treatment platelet reactivity to aspirin in patients after myocardial infarction. Biomedicine & Pharmacotherapy. 147. 112618–112618. 8 indexed citations
4.
Sikora, Joanna, et al.. (2022). The Importance of Platelets Response during Antiplatelet Treatment after Ischemic Stroke—Between Benefit and Risk: A Systematic Review. International Journal of Molecular Sciences. 23(3). 1043–1043. 7 indexed citations
5.
Sikora, Joanna, et al.. (2021). Hypercoagulability as Measured by Thrombelastography May Be Associated with the Size of Acute Ischemic Infarct—A Pilot Study. Diagnostics. 11(4). 712–712. 6 indexed citations
7.
Niezgoda, Piotr, Joanna Sikora, Katarzyna Buszko, et al.. (2020). Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor — NARCOTIC trial. Cardiology Journal. 29(3). 432–440. 5 indexed citations
8.
Sikora, Joanna, et al.. (2020). The Prognostic Value of High Platelet Reactivity in Ischemic Stroke Depends on the Etiology: A Pilot Study. Journal of Clinical Medicine. 9(3). 859–859. 8 indexed citations
9.
Sikora, Joanna, et al.. (2020). High On-Treatment Platelet Reactivity Affects the Extent of Ischemic Lesions in Stroke Patients Due to Large-Vessel Disease. Journal of Clinical Medicine. 9(1). 251–251. 10 indexed citations
10.
Adamski, Piotr, Katarzyna Buszko, Joanna Sikora, et al.. (2019). Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor. Scientific Reports. 9(1). 3924–3924. 21 indexed citations
11.
Sikora, Joanna, Adam Sikora, Michał Piotr Marszałł, et al.. (2017). Impact of levosimendan on platelet function. Thrombosis Research. 159. 76–81. 3 indexed citations
12.
Adamski, Piotr, Małgorzata Ostrowska, Joanna Sikora, et al.. (2017). Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study. BMJ Open. 7(4). e013218–e013218. 11 indexed citations
15.
Adamski, Piotr, Joanna Sikora, Adam Sikora, et al.. (2016). Which platelet function test best reflects the in vivo plasma concentrations of ticagrelor and its active metabolite?. Thrombosis and Haemostasis. 116(12). 1140–1149. 12 indexed citations
17.
Kasprzak, Michał, Karolina Obońska, Julia Maria Kubica, et al.. (2015). Variability of prasugrel antiplatelet effect in patients with acute coronary syndrome. Medical Research Journal. 3(3). 117–124. 2 indexed citations
18.
Kubica, Jacek, Piotr Adamski, Małgorzata Ostrowska, et al.. (2015). Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial. European Heart Journal. 37(3). 245–252. 187 indexed citations
19.
Fabczak, Hanna, et al.. (1999). Ciliary and flagellar activity control in eukaryotic cells by second messengers: calcium ions and cyclic nucleotides. Acta Protozoologica. 38(2). 87–96. 7 indexed citations
20.
Fabczak, Hanna, et al.. (1996). Ionic mechanisms controlling photophobic responses in the ciliate Blepharisma japonicum. Acta Protozoologica. 35(3). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026